Suppr超能文献

Criminal or bystander: imatinib and second primary malignancy in GIST patients.

作者信息

Kanda Tatsuo

机构信息

Sanjo General Hospital, Sanjo City, Niigata, Japan.

出版信息

Chin J Cancer Res. 2013 Oct;25(5):490-2. doi: 10.3978/j.issn.1000-9604.2013.10.15.

Abstract
摘要

相似文献

1
Criminal or bystander: imatinib and second primary malignancy in GIST patients.
Chin J Cancer Res. 2013 Oct;25(5):490-2. doi: 10.3978/j.issn.1000-9604.2013.10.15.
5
Adherence to Guidelines for Adjuvant Imatinib Therapy for GIST: A Multi-institutional Analysis.
J Gastrointest Surg. 2015 Jun;19(6):1022-8. doi: 10.1007/s11605-015-2782-7. Epub 2015 Mar 3.
8
Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance.
Cancer Treat Rev. 2012 Aug;38(5):467-72. doi: 10.1016/j.ctrv.2011.10.001. Epub 2011 Oct 27.
9
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
Genes Chromosomes Cancer. 2008 Oct;47(10):853-9. doi: 10.1002/gcc.20589.
10
Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
Therap Adv Gastroenterol. 2021 Apr 15;14:17562848211008177. doi: 10.1177/17562848211008177. eCollection 2021.

引用本文的文献

1
Altered expression profile of micrornas in gastric stromal tumor.
J Huazhong Univ Sci Technolog Med Sci. 2015 Dec;35(6):842-850. doi: 10.1007/s11596-015-1516-0. Epub 2015 Dec 16.
3
The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies.
J Gastrointest Cancer. 2015 Dec;46(4):408-12. doi: 10.1007/s12029-015-9759-3.
5
microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.
Clin Exp Med. 2015 May;15(2):137-44. doi: 10.1007/s10238-014-0280-y. Epub 2014 Apr 5.
6
MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.
Tumour Biol. 2014 May;35(5):4209-17. doi: 10.1007/s13277-013-1551-z. Epub 2013 Dec 29.

本文引用的文献

1
Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate.
Chin J Cancer Res. 2013 Oct;25(5):486-7. doi: 10.3978/j.issn.1000-9604.2013.10.13.
3
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
Lancet Oncol. 2012 Mar;13(3):265-74. doi: 10.1016/S1470-2045(11)70299-6. Epub 2011 Dec 6.
4
Co-existence of gastrointestinal stromal tumors with other primary neoplasms.
Hepatogastroenterology. 2011 May-Jun;58(107-108):824-30.
5
Occurrence of other tumors in patients with GIST.
Surg Oncol. 2010 Dec;19(4):e140-3. doi: 10.1016/j.suronc.2010.06.004. Epub 2010 Aug 2.
6
Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor.
Ann Oncol. 2010 Oct;21(10):2107-2111. doi: 10.1093/annonc/mdq078. Epub 2010 Mar 26.
9
Coexistence of gastrointestinal stromal tumors with other neoplasms.
J Gastroenterol. 2007 Aug;42(8):641-9. doi: 10.1007/s00535-007-2082-4. Epub 2007 Aug 24.
10
Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations.
Am J Surg Pathol. 2007 Jan;31(1):113-20. doi: 10.1097/01.pas.0000213307.05811.f0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验